Donjetë Simnica

HLA class I–associated expansion of TRBV11-2 T cells in multisystem inflammatory syndrome in children

Rebecca A. Porritt, Lisa Paschold, Magali Noval Rivas et al. · Journal of Clinical Investigation · 2021 · 184 citations · Full text

Multisystem Inflammatory Syndrome, Adaptive Immune System, Immunodeficiencies +23

T cell receptor next-generation sequencing reveals cancer-associated repertoire metrics and reconstitution after chemotherapy in patients with hematological and solid tumors

Donjetë Simnica, Nuray Akyüz, Simon Schliffke et al. · OncoImmunology · 2019 · 62 citations · Full text

Age-specific Tcr Metrics, Solid Tumors, T-regulatory Cell +16

PD-L1 targeting and subclonal immune escape mediated by PD-L1 mutations in metastatic colorectal cancer

Alexander Stein, Donjetë Simnica, Christoph Schultheiß et al. · Journal for ImmunoTherapy of Cancer · 2021 · 62 citations · Full text

Efficacy of Ipilimumab vs FOLFOX in Combination With Nivolumab and Trastuzumab in Patients With Previously Untreated <i>ERBB2</i>-Positive Esophagogastric Adenocarcinoma

Alexander Stein, Lisa Paschold, Joseph Tintelnot et al. · JAMA Oncology · 2022 · 54 citations · Full text

Avelumab and cetuximab in combination with FOLFOX in patients with previously untreated metastatic colorectal cancer (MCRC): Final results of the phase II AVETUX trial (AIO-KRK-0216).

Alexander Stein, Mascha Binder, Eray Goekkurt et al. · Journal of Clinical Oncology · 2020 · 51 citations

Clinical Immunology, Immunodeficiencies, Immunology +26